Mereo Stock Market Value

MREO
 Stock
  

USD 1.18  0.11  8.53%   

Mereo Biopharma's market value is the price at which a share of Mereo Biopharma stock trades on a public exchange. It measures the collective expectations of Mereo Biopharma Group investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Mereo Biopharma Group and determine expected loss or profit from investing in Mereo Biopharma over a given investment horizon. Additionally, see Mereo Biopharma Hype Analysis, Mereo Biopharma Correlation, Mereo Biopharma Valuation, Mereo Biopharma Volatility, as well as analyze Mereo Biopharma Alpha and Beta and Mereo Biopharma Performance.
Symbol


Is Mereo Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo Biopharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
156.2 M
Return On Assets
-0.14
Return On Equity
0.35
The market value of Mereo Biopharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo Biopharma's market value can be influenced by many factors that don't directly affect Mereo Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Mereo Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Mereo Biopharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mereo Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mereo Biopharma.
0.00
08/13/2021
No Change 0.00  0.0 
In 11 months and 27 days
08/08/2022
0.00
If you would invest  0.00  in Mereo Biopharma on August 13, 2021 and sell it all today you would earn a total of 0.00 from holding Mereo Biopharma Group or generate 0.0% return on investment in Mereo Biopharma over 360 days. Mereo Biopharma is related to or competes with Csl, and La Z. Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of on...More

Mereo Biopharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mereo Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mereo Biopharma Group upside and downside potential and time the market with a certain degree of confidence.

Mereo Biopharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mereo Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mereo Biopharma's standard deviation. In reality, there are many statistical measures that can use Mereo Biopharma historical prices to predict the future Mereo Biopharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Mereo Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Mereo Biopharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.071.3213.35
Details
Intrinsic
Valuation
LowReal ValueHigh
0.163.1215.16
Details
Naive
Forecast
LowNext ValueHigh
0.024581.2313.25
Details
1 Analysts
Consensus
LowTarget PriceHigh
8.009.0010.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mereo Biopharma. Your research has to be compared to or analyzed against Mereo Biopharma's peers to derive any actionable benefits. When done correctly, Mereo Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Mereo Biopharma Group.

Mereo Biopharma Group Backtested Returns

Mereo Biopharma is dangerous given 3 months investment horizon. Mereo Biopharma Group has Sharpe Ratio of 0.19, which conveys that the firm had 0.19% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use Mereo Biopharma Group market data together with company specific technical indicators. We were able to analyze and collect data for twenty-one different technical indicators, which can help you to evaluate if expected returns of 2.26% are justified by taking the suggested risk. Use Mereo Biopharma Group Downside Deviation of 9.08, risk adjusted performance of 0.1907, and Mean Deviation of 8.14 to evaluate company specific risk that cannot be diversified away.
Mereo Biopharma holds a performance score of 14 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.5014, which conveys a somewhat significant risk relative to the market. Let's try to break down what Mereo's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mereo Biopharma will likely underperform. Although it is essential to pay attention to Mereo Biopharma Group price patterns, it is also good to be reasonable about what you can do with equity historical price patterns. Our philosophy towards estimating future potential of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Mereo Biopharma expected return of 2.26 will be sustainable into the future, we have found twenty-one different technical indicators, which can help you to check if the expected returns are sustainable. Use Mereo Biopharma Group variance, value at risk, as well as the relationship between the Value At Risk and skewness to analyze future returns on Mereo Biopharma Group.

Auto-correlation

    
  -0.17  

Insignificant reverse predictability

Mereo Biopharma Group has insignificant reverse predictability. Overlapping area represents the amount of predictability between Mereo Biopharma time series from 13th of August 2021 to 9th of February 2022 and 9th of February 2022 to 8th of August 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mereo Biopharma Group price movement. The serial correlation of -0.17 indicates that over 17.0% of current Mereo Biopharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.17
Spearman Rank Test-0.06
Residual Average0.0
Price Variance0.14

Mereo Biopharma Group lagged returns against current returns

Autocorrelation, which is Mereo Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mereo Biopharma's stock expected returns. We can calculate the autocorrelation of Mereo Biopharma returns to help us make a trade decision. For example, suppose you find that Mereo Biopharma stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   
Share
       Timeline  

Mereo Biopharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mereo Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mereo Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mereo Biopharma stock over time.
   Current vs Lagged Prices   
Share
       Timeline  

Mereo Biopharma Lagged Returns

When evaluating Mereo Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mereo Biopharma stock have on its future price. Mereo Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mereo Biopharma autocorrelation shows the relationship between Mereo Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Mereo Biopharma Group.
   Regressed Prices   
Share
       Timeline  

Be your own money manager

Our tools can tell you how much better you can do entering a position in Mereo Biopharma without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Mereo Biopharma Group using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Mereo Biopharma Hype Analysis, Mereo Biopharma Correlation, Mereo Biopharma Valuation, Mereo Biopharma Volatility, as well as analyze Mereo Biopharma Alpha and Beta and Mereo Biopharma Performance. Note that the Mereo Biopharma Group information on this page should be used as a complementary analysis to other Mereo Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Mereo Stock analysis

When running Mereo Biopharma Group price analysis, check to measure Mereo Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo Biopharma is operating at the current time. Most of Mereo Biopharma's value examination focuses on studying past and present price action to predict the probability of Mereo Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mereo Biopharma's price. Additionally, you may evaluate how the addition of Mereo Biopharma to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Mereo Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mereo Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mereo Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...